ZL-1109

· Zai Lab (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZL-1109, covering 2025-12-29 to 2025-12-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease [Phase 3]

See pricing